Mineralys Therapeutics, Inc. (MLYS) forecast
Mineralys Therapeutics, Inc. (MLYS) forecast: price $20.80, trailing P/E -5.06, forward P/E 10.94. How to read the street's path.
The live MLYS price is $20.80. Trailing P/E is -5.06 and forward P/E is 10.94. The forecast that matters is the earnings path those ratios imply, not a single target price.
A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.
Use this page for the MLYS forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.
Learn: Forward P/E · Analyst forecast · DCF
Full MLYS quote · Dividends · Price prediction · Academy
Questions
What is MLYS's forward P/E?
The latest forward P/E on Stocklytics is 10.94, against a trailing P/E of -5.06 and a price of $20.80.
Is the analyst target the forecast?
It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.